XAGE Stock Analysis — LONGEVITY HEALTH HOLDINGS, INC. (Consumer Defensive >> Household & Personal Products)
XAGE FAQ
What is XAGE's ROE?
LONGEVITY HEALTH HOLDINGS, INC. reports a Return on Equity (ROE) of 99.07%.
What is XAGE's dividend yield?
LONGEVITY HEALTH HOLDINGS, INC. offers a dividend yield of 0.00%.
What is XAGE's Quality Score?
Our AI rates XAGE's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy XAGE?
Our AI Timing Score for XAGE is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does XAGE belong to?
LONGEVITY HEALTH HOLDINGS, INC. is classified under the Consumer Defensive >> Household & Personal Products sector on the NASDAQ exchange
XAGE AI Analysis Summary
Our AI summary for XAGE: LONGEVITY HEALTH HOLDINGS, INC. (NASDAQ), Consumer Defensive >> Household & Personal Products sector. The stock currently trades at a P/E of 0.00, ROE of 99.07%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.21
Price
-0.02
(-6.67%)
Day Change
|
|
|---|
XAGE, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.21 |
| PBV / Sector |
-0.09 / 19.05
|
| Earning Per Share | -2.41 |
| PE / Sector |
N/A / 19.66
|
| PEG or PE/Growth / Sector |
N/A / 0.56
|
| Average 1M Daily Value |
543.992010000000
|
| Average 1W Daily Value |
327.600000000000
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:42 |
| Symbol | XAGE |
| Name | LONGEVITY HEALTH HOLDINGS, INC. |
| Sector | Consumer Defensive >> Household & Personal Products |
| Market | NASDAQ |
| Listed Shares | 2.48 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 0.59 / 40,621.30 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2403 Sidney Street, Pittsburgh, PA, United States, 15203
Phone: 919 313 9633
Website: https://healthxage.com
Description: Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
ME vs SECTOR Consumer Defensive >> Household & Personal Products
Click a bubble to view stock details · Bubble size represents market capitalization share
Google